Interventions that promote physical activity have significant benefits in terms of increasing physical activity, decreasing sedentary time, and improving quality of life in patients with asthma.
Combustion-related nitrogen dioxide (NO2) accounted for 1.85 million new pediatric asthma cases worldwide in 2019.
Researchers conducted a study to compare the effects of intravenous vs oral antibiotics therapy in patients with a pulmonary infection caused by Pseudomonas aeruginosa secondary to cystic fibrosis.
A phase 3 clinical trial evaluated the monoclonal antibody lenzilumab for improving survival without mechanical ventilation in COVID-19 pneumonia.
Researchers conducted a study to determine whether the lactate dehydrogenase to albumin ratio is an independent prognostic factor predictive of in-hospital mortality in patients with lower respiratory tract infection.
Can blockade of the interleukin-1 or IL-6 pathways shorten the time to clinical improvement in patients with COVID-19 or hypoxic respiratory failure?
Investigators conducted a study to determine whether double masking or fit modifications improve the performance of face masks as source control devices for respiratory aerosols.
PRoVENT–COVID trial results refute the assumption that patients with COVID-19-related ARDS present with consistent respiratory subphenotypes.
Researchers investigated the cause of dyspnea in individuals with long-haul COVID and also screened the patients for myalgic encephalomyelitis/chronic fatigue syndrome.
People with type 2 diabetes have a high risk of catching pneumonia. Researchers sought to discover which drugs made people more susceptible to this serious lung infection.
